Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/2020 Withdrawn
Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/2020 Withdrawn
Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/2020 Withdrawn
Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn
Herbal medicinal product: Lini semen, Linum usitatissimum L., C: ongoing call for scientific data
Herbal medicinal product: Urticae radix, Urtica dioica L.,Urtica urens L., F: Assessment finalised
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Human medicines European public assessment report (EPAR): Gencebok, caffeine citrate, Date of authorisation: 19/08/2020, Revision: 8, Status: Authorised
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 21 January 2025, 09:30 (CET) to 21 January 2025, 13:00 (CET)
Summary of the Medicine Shortages SPOC Working Party meeting on 21 January 2025
EMEA-003043-PIP01-21-M01
CTIS newsflash - 11 March 2025